Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SLIK6 | Q9H5Y7 | SLIT and NTRK-like protein 6 | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | DeafnessBladder cancerUreteral cancer | Clinical-translation mediation | 2 | 0.28 | ||
| SPP2B | Q8TCT7 | Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1) | EnzymesPredicted membrane proteins | 9 | Fusion and delivery mediationReceptor-signaling mediation | 2 | 0.28 | |||
| SPTC2 | O15270 | Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) | 1 | Metabolism mediation | 2 | 0.28 | ||||
| SSR3 | P32745 | Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Alzheimer diseaseCushing syndromeStomach cancer | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.28 | ||
| STYK1 | Q6J9G0 | Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.28 | |||
| T106B | Q9NUM4 | Transmembrane protein 106B | Disease related genesHuman disease related genesPotential drug targets | 1 | Amyotrophic lateral sclerosisLeukodystrophy | Fusion and delivery mediation | 2 | 0.28 | ||
| TIMD4 | Q96H15 | T-cell immunoglobulin and mucin domain-containing protein 4 (TIMD-4) (T-cell immunoglobulin mucin receptor 4) (TIM-4) (T-cell membrane protein 4) | Plasma proteinsPredicted membrane proteins | 1 | Clinical-translation mediationImmune mediation | 2 | 0.28 | |||
| TLR4 | O00206 | Toll-like receptor 4 (hToll) (CD antigen CD284) | CD markersFDA approved drug targetsHuman disease related genes | 1 | Age-related macular degenerationAllergic/hypersensitivity disorderDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.28 | ||
| TM101 | Q96IK0 | Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130) | 8 | Immune mediationReceptor-signaling mediation | 2 | 0.28 | ||||
| TM139 | Q8IV31 | Transmembrane protein 139 | Predicted membrane proteinsTransporters | 1 | Other mediation | 2 | 0.28 |